News
4d
Zacks.com on MSNHow Will Pfizer's Oncology Drugs Perform in Q2 Earnings?PFE's oncology unit is in focus ahead of Q2 results, with key drugs facing both rising demand and market pressure.
Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...
You can buy shares of Healthpeak Properties and Pfizer with well less than $100 at the moment. At the moment, anyone with ...
A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to pharmaceutical companies Pfizer and Eli Lilly.
Sino Biopharma will acquire LaNova Medicines, which has licensed cancer drugs for Merck and AstraZeneca, for $951 million.
Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...
Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient ...
Pfizer has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control ...
The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...
Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough ...
But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results